论文部分内容阅读
持续皮下输入胰岛素(Continuous subcutaneous Insulin lnfusion,CSII)治疗糖尿病,较合乎生理需要胰岛素的规律,能保持一个比较稳定的基础释放剂量;另于每次餐前追加脉冲剂量,可使血糖持续地控制在正常或接近正常水平。Pickup等于1977年首创一种携带式双速注射泵(Mill Hill输入器)治疗12例糖尿病,效果良好。其后,国外续有类似报道,但国内报道者尚少。近两年来我们应用此法治疗6例糖尿病患者,获得良好效果,现报道如下: 1 临床资料 本组中男、女各3例;年龄23～50岁,平均34岁;病程3～12年;有酮症史3例;
Continuous subcutaneous insulin infusion (CSII) in the treatment of diabetes, compared with the laws of physiologically required insulin, to maintain a relatively stable basis for the release of the other in each additional pulse dose before meals, blood glucose can continue to control the Normal or near normal levels. Pickup was the first of a kind of portable two-speed syringe pump (Mill Hill input device) in 1977 to treat 12 cases of diabetes with good effect. Since then, there have been similar reports in foreign countries, but there are still few domestic reporters. In the past two years, we apply this method to treat 6 patients with diabetes, and achieved good results, are reported as follows: 1 clinical data in this group, 3 males and 3 females; aged 23 to 50 years, mean 34 years; duration of 3 to 12 years; A history of ketosis in 3 cases;